Scintigraphic imaging of carcinoid tumours with 131I-metaiodobenzylguanidine.

作者信息

Fischer M, Kamanabroo D, Sonderkamp H, Proske T

出版信息

Lancet. 1984 Jul 21;2(8395):165. doi: 10.1016/s0140-6736(84)91081-x.

DOI:10.1016/s0140-6736(84)91081-x

PMID:6146062

Abstract

摘要

相似文献

Scintigraphic imaging of carcinoid tumours with 131I-metaiodobenzylguanidine.

Lancet. 1984 Jul 21;2(8395):165. doi: 10.1016/s0140-6736(84)91081-x.

Combined diagnostic imaging with 131I-metaiodobenzylguanidine and 111In-pentetreotide in carcinoid tumours.

Eur J Cancer. 1996 Oct;32A(11):1924-32. doi: 10.1016/0959-8049(96)00241-9.

Imaging of carcinoid tumors with iodine-123 metaiodobenzylguanidine.

J Nucl Med. 1987 Dec;28(12):1907-10.

Acute liver necrosis induced by iodine-131-MIBG in the treatment of metastatic carcinoid tumors.

J Nucl Med. 1997 Jul;38(7):1024-6.

I-123 MIBG imaging of metastatic carcinoid tumor from the rectum.

Clin Nucl Med. 1995 Apr;20(4):357-60. doi: 10.1097/00003072-199504000-00014.

I-131 MIBG detection of metastatic hepatic carcinoid.

Clin Nucl Med. 1994 Aug;19(8):751. doi: 10.1097/00003072-199408000-00028.

Iodine-131 metaiodobenzylguanidine scintigraphy of carcinoid tumors.

J Nucl Med. 1986 Nov;27(11):1691-6.

Diagnosis and treatment of a carcinoid tumor using iodine-131 meta-iodobenzylguanidine.

Clin Nucl Med. 1986 Mar;11(3):150-2. doi: 10.1097/00003072-198603000-00002.

[Iodine-131 metaiodobenzylguanidine and carcinoid tumors].

Gastroenterol Clin Biol. 1987 Aug-Sep;11(8-9):612-4.

The use of 131I-MIBG in the imaging of metastatic carcinoid tumours.

Br J Cancer. 1988 Nov;58(5):663-4. doi: 10.1038/bjc.1988.281.

引用本文的文献

Norepinephrine Transporter as a Target for Imaging and Therapy.

J Nucl Med. 2017 Sep;58(Suppl 2):39S-53S. doi: 10.2967/jnumed.116.186833.

Fluorine-18-fluorodihydroxyphenylalanine Positron-emission Tomography Scans of Neuroendocrine Tumors (Carcinoids and Pheochromocytomas).

J Clin Imaging Sci. 2017 May 22;7:20. doi: 10.4103/jcis.JCIS_107_16. eCollection 2017.

Successful and unsuccessful approaches to imaging carcinoids: comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue.

Eur J Nucl Med. 1996 Feb;23(2):131-40. doi: 10.1007/BF01731835.

Radiopharmaceutical diagnosis and therapy of sympatho-medullary disorders.

Ann Nucl Med. 1996 Feb;10(1):9-12. doi: 10.1007/BF03165048.

Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours.

Eur J Nucl Med. 1994 Jun;21(6):561-81. doi: 10.1007/BF00173045.

Uptake of 131I-MIBG by medullary carcinoma of thyroid in familial cases.

Eur J Nucl Med. 1986;12(2):77-9. doi: 10.1007/BF00364733.

The use of 131I-MIBG in the imaging of metastatic carcinoid tumours.

Br J Cancer. 1988 Nov;58(5):663-4. doi: 10.1038/bjc.1988.281.

Glomerular filtration rate and the kinetics of 123I-metaiodobenzylguanidine.

Eur J Nucl Med. 1989;15(9):618-23. doi: 10.1007/BF00256941.

The role of I-131-MIBG in the diagnosis and therapy of carcinoids.

Eur J Nucl Med. 1987;13(4):187-91. doi: 10.1007/BF00256489.

The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG). 5 years of experience.

Eur J Nucl Med. 1990;16(4-6):325-35. doi: 10.1007/BF00842788.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验